BridgeMD
New treatment option for Diabetic Retinopathy (DR)
Official title Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center
ClinicalTrials.gov ID: NCT07519707
What this study is testing
- What it's testing
- The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of diabetes mellitus with or without diabetic retinopathy
- Scheduled visit to ZSFG clinic is specifically for diabetes mellitus or diabetic retinopathy care
- Able to speak and understand English or Spanish
You likely can't join if
- Unable to view or understand the videos due to significant vision obstruction or impairment
The study team makes the final eligibility decision.
Where it's taking place
- San Francisco, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Francisco, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.